6-Bromoimidazo[1,2-a]pyrimidine-3-carbaldehyde(CAS: 865156-67-8)

The compound 6-Bromoimidazo[1,2-a]pyrimidine-3-carbaldehyde (CAS: 865156-67-8) should comply with the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazardous substances. It may also be subject to the European Union's Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulations. Additionally, it is advisable to check with the FDA and EPA for specific requirements related to research, production, and import/export operations.

Yes, there are alternatives to 6-Bromoimidazo[1,2-a]pyrimidine-3-carbaldehyde in synthesis. Common alternatives include 6-Aminimidazo[1,2-a]pyrimidine-3-carbaldehyde and 6-Chlorimidazo[1,2-a]pyrimidine-3-carbaldehyde. Researchers may also explore related analogs such as 6-Halogenimidazo[1,2-a]pyrimidine-3-carbaldehydes where halogens other than bromine can be used as substituents.

The research trend for 6-Bromoimidazo[1,2-a]pyrimidine-3-carbaldehyde (CAS: 865156-67-8) is focused on its potential applications in drug discovery and development. This compound has been explored for its biological activities, particularly in the treatment of various diseases. Market trends indicate increasing interest in its use as a starting material or intermediate in pharmaceuticals and chemical synthesis. Recent studies highlight its role in antiviral and anticancer research.

Waste containing 6-Bromoimidazo[1,2-a]pyrimidine-3-carbaldehyde (CAS: 865156-67-8) should be collected in appropriate containers and sealed to prevent spillage. Incineration is a common method for disposal, provided it meets the necessary emission standards. Alternatively, professional waste disposal services can handle the waste, ensuring it is processed in an environmentally friendly manner. Always follow local regulations and guidelines for hazardous waste management to protect the environment and public health.